BAXTER INTERNATIONAL INC/ US0718131099 /
14/06/2024 09:05:09 | Chg. +0.95 | Volume | Bid16:03:10 | Ask16:03:10 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
31.61EUR | +3.08% | 0 Turnover: - |
31.16Bid Size: 257 | 31.51Ask Size: 257 | 15.92 bill.EUR | - | - |
GlobeNewswire
15:00
CMS Improves Star Ratings to 3.5 Stars for Clover Health PPO Medicare Advantage Plans for 2025 Payme...
GlobeNewswire
12/06
2024 RealTrends + Tom Ferry The Thousand List Recognizes 44 eXp Realty Agents and Teams
GlobeNewswire
12/06
2024 Report: LGBTQ+ Advertising Influential Over Brand Perceptions & Purchase Decisions
GlobeNewswire
04/06
Wood Mackenzie appoints Xizhou Zhou as new head of Power and Renewables Business
GlobeNewswire
16/05
US November election results could decelerate energy transition, with $1 trillion in energy investme...
GlobeNewswire
15/05
Investigation Alert Baxter International, Eagle Pharmaceuticals, BioXcel Therapeutics, and ImmunityB...
GlobeNewswire
01/05
Clover Health to Participate at Bank of America 2024 Healthcare Conference and Present at 2024 Leeri...
GlobeNewswire
29/04
CleanTech Lithium to Present at Metals & Mining Virtual Investor Conference May 1st
GlobeNewswire
23/04
ProvisionAi Named to Inbound Logistics Top 100 Logistics IT Providers Award 2024
GlobeNewswire
22/04
Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial Officer
GlobeNewswire
04/04
Clover Health Provides Notice Associated with Previously Disclosed Settlement of Shareholder Derivat...
GlobeNewswire
04/04
ProvisionAi Hosts Theatre Session on Supply Chain Challenges at the Gartner Supply Chain Symposium/X...